[HTML][HTML] Omicron BA. 1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

…, C Parker, D Rust, S Mehta, E de Windt… - The Lancet Infectious …, 2023 - thelancet.com
Background The omicron BA.1 bivalent booster is used globally. Previous open-label studies
of the omicron BA.1 (Moderna mRNA-1273.214) booster showed superior neutralising …

A randomized trial comparing omicron-containing boosters with the original Covid-19 vaccine mRNA-1273

…, B Girard, C Parker, D Rust, S Mehta, E Windt… - medRxiv, 2023 - medrxiv.org
Background Omicron-containing bivalent boosters are available worldwide. Results of a
large, randomized, active-controlled study are presented. Methods This phase 3, randomized, …

Safety and Immunogenicity of the mRNA-1273 Coronavirus Disease 2019 Vaccine in Solid Organ Transplant Recipients

…, I Leony Lasso, E de Windt… - The Journal of …, 2024 - academic.oup.com
Background Immunosuppressed individuals, including solid organ transplant recipients (SOTRs),
are at high risk for severe COVID-19. Methods This open-label, phase 3b trial …

[HTML][HTML] The development of sarcoidosis in patients receiving daclizumab: a case series from multiple clinical trials

…, BM Elicker, TV Colby, S Kwon, E de Windt… - Respiratory …, 2019 - Elsevier
Introduction Several drugs have been associated with druginduced sarcoidosis-like reactions
(DISRs) that are clinically indistinguishable from sarcoidosis. Daclizumab is a humanized …

2363. Three-Month Safety and Immunogenicity of Bivalent SARS-CoV-2 Omicron-Containing Booster Vaccines: Interim Results From a Phase 3, Randomized …

…, B Girard, K Sellers, E de Windt… - Open Forum …, 2023 - academic.oup.com
Background Updated COVID-19 vaccines have been developed to help broaden protection
against circulating SARS-CoV-2 variants. Here we present a 3-month interim analysis from a …

A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273 (preprint)

…, B Girard, C Parker, D Rust, S Mehta, E de Windt… - 2023 - pesquisa.bvsalud.org
BackgroundOmicron-containing bivalent boosters are available worldwide. Results of a
large, randomized, active-controlled study are presented. MethodsThis phase 3, randomized, …

[PDF][PDF] The hypoxia-inducible microRNA cluster miR-199a∼ 214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation

…, PA da Costa Martins, P Schrauwen, LJ De Windt - Cell metabolism, 2013 - cell.com
Peroxisome proliferator-activated receptor δ (PPARδ) is a critical regulator of energy
metabolism in the heart. Here, we propose a mechanism that integrates two deleterious …

MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo

…, S Meloche, J Pouysségur, G Pagès, LJ De Windt… - Circulation, 2004 - Am Heart Assoc
Background— Myocardial infarction causes a rapid and largely irreversible loss of cardiac
myocytes that can lead to sudden death, ventricular dilation, and heart failure. Members of the …

[BOOK][B] Land and people in Holywell-cum-Needingworth: structures of tenure and patterns of social organization in an East Midlands village, 1252-1457

EB DeWindt - 1972 - books.google.com
… She it was, described in the Chronicon as "genere nobilis sed fidei devotione nobilior,"
who bestowed many precious gifts upon the abbey and "terram de Haliwelle et ecclesiam de

Witchcraft and Conflicting Visions of the Ideal Village Community

AR DeWindt - Journal of British Studies, 1995 - cambridge.org
DE WINDT house where Elizabeth Pickering lay after giving birth.Alice was demonstrating,
again, her neighborly interest in the new baby and its mother, and her presumption of a right, …